(PRESS RELEASE) SARREBRUCK / VIENNE, 17-Feb-2021 — /EuropaWire/ — Dans la lutte contre le virus SRAS-CoV-2, un grand nombre d’entreprises pharmaceutiques recherchent de nouvelles approches pour combattre la pandémie. Outre les vaccins, des efforts intensifs de recherche et développement à … Read the full press release
Posted in Austria, France, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science
Tagged allergies, anti-SARS-CoV-2, azélastine, biotechnologie, CEBINA, COVID-19, médicament antiallergique Pollival, pandémie, Pollival, professeur Ferenc Jakab, professeur Robert Konrat, Sophie Zettl, sprays nasaux, SRAS-CoV-2, URSAPHARM Arzneimittel
(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release
Posted in Austria, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science
Tagged anti-allergic medication Pollival, anti-COVID therapeutics, antihistamine drug, antiviral properties, azelastine, azelastine hydrochloride, CEBINA GmbH, Central European Biotech Incubator and Accelerator, clinical trial, COVID-19, COVID-19 medication, Covid-19 pandemic, COVID-19 treatment, nasal spray, ophthalmology, Pollival, Prof Dr Robert Konrat, Prof Dr. Ferenc Jakab, re-purpose drugs, SARS-CoV-2, Sophie Zettl, University of Pécs, University of Vienna, URSAPHARM Arzneimittel GmbH, viral spread
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?